-
2
-
-
77957261734
-
Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension
-
Jansook, P., Stefánsson, E., Thorsteinsdó ttir, M., et al. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension. Eur. J. Pharm. Biopharm. 76:208-214, 2010
-
(2010)
Eur. J. Pharm. Biopharm
, vol.76
, pp. 208-214
-
-
Jansook, P.1
Stefánsson, E.2
Thorsteinsdóttir, M.3
-
3
-
-
84868200133
-
Topical drug delivery to the eye: Dorzolamide
-
Loftsson, T., Jansook, P., and Stefánsson, E. Topical drug delivery to the eye: Dorzolamide. Acta. Ophthalmol. 90:603-608, 2012
-
(2012)
Acta. Ophthalmol
, vol.90
, pp. 603-608
-
-
Loftsson, T.1
Jansook, P.2
Stefánsson, E.3
-
4
-
-
0034871011
-
A systematic review of the associations between dose regimens and medication compliance
-
Claxton, A.J., Cramer, J., and Pierce, C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 23:1296-1310, 2001
-
(2001)
Clin. Ther
, vol.23
, pp. 1296-1310
-
-
Claxton, A.J.1
Cramer, J.2
Pierce, C.3
-
5
-
-
0034760617
-
Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions
-
Ikeda, H., Sato, M., Tsukamoto, H., et al. Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions. Yakugaku. Zasshi. 121:799-806, 2001
-
(2001)
Yakugaku. Zasshi
, vol.121
, pp. 799-806
-
-
Ikeda, H.1
Sato, M.2
Tsukamoto, H.3
-
6
-
-
64049105397
-
-
Council of Europe. 5th ed. France: S
-
Council of Europe. European Pharmacopoeia. 5th ed. France: S, 2006
-
(2006)
European Pharmacopoeia
-
-
-
8
-
-
11844256915
-
Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration
-
Sigurdsson, H.H., Stefánsson, E., Gudmundsdó ttir, E., Eysteinsson, T., Thorsteinsdó ttir, M., and Loftsson, T. Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration. J. Control. Release. 102:255-262, 2005
-
(2005)
J. Control. Release
, vol.102
, pp. 255-262
-
-
Sigurdsson, H.H.1
Stefánsson, E.2
Gudmundsdóttir, E.3
Eysteinsson, T.4
Thorsteinsdóttir, M.5
Loftsson, T.6
-
9
-
-
79953251219
-
Self-Assembly of cyclodextrins: The effect of the guest molecule
-
Messner, M., Kurkov, S.V., Flavià-Piera, R., Brewster, M.E., and Loftsson, T. Self-Assembly of cyclodextrins: The effect of the guest molecule. Int. J. Pharm. 408:235-247, 2011
-
(2011)
Int. J. Pharm
, vol.408
, pp. 235-247
-
-
Messner, M.1
Kurkov, S.V.2
Flavià-Piera, R.3
Brewster, M.E.4
Loftsson, T.5
-
10
-
-
34248395551
-
How red is a white eyé Clinical grading of normal conjunctival hyperaemia
-
Murphy, P.J., Lau, J.S.C., Sim, M.M.L., and Woods, R.L. How red is a white eyé Clinical grading of normal conjunctival hyperaemia. Eye. 21:633-638, 2006
-
(2006)
Eye
, vol.21
, pp. 633-638
-
-
Murphy, P.J.1
Lau, J.S.C.2
Sim, M.M.L.3
Woods, R.L.4
-
11
-
-
0020565258
-
The validation of visual analogue scales as ratio scale measures for chronic and experimental pain
-
Price, D.D., McGrath, P.A., Rafii, A., and Buckingham, B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 17:45-56, 1983
-
(1983)
Pain
, vol.17
, pp. 45-56
-
-
Price, D.D.1
McGrath, P.A.2
Rafii, A.3
Buckingham, B.4
-
12
-
-
84555187190
-
Topical dexamethasonecyclodextrin microparticle eye drops for diabetic macular edema
-
Tanito, M., Hara, K., Takai, Y., et al. Topical dexamethasonecyclodextrin microparticle eye drops for diabetic macular edema. Invest. Ophthalmol. Vis. Sci. 52:7944-7948
-
Invest. Ophthalmol. Vis. Sci
, vol.52
, pp. 7944-7948
-
-
Tanito, M.1
Hara, K.2
Takai, Y.3
-
13
-
-
33745001604
-
Mucin structure, aggregation, physiological functions and biomedical applications
-
Bansil, R., and Turner, B.S. Mucin structure, aggregation, physiological functions and biomedical applications. Curr. Opin. Coll. Interface. Sci. 11:164-170, 2006
-
(2006)
Curr. Opin. Coll. Interface. Sci
, vol.11
, pp. 164-170
-
-
Bansil, R.1
Turner, B.S.2
-
14
-
-
84862322838
-
Drug permeation through biomembranes: Cyclodextrins and the unstirred water layer
-
Loftsson, T. Drug permeation through biomembranes: Cyclodextrins and the unstirred water layer. Pharmazie. 67:363-370, 2012
-
(2012)
Pharmazie
, vol.67
, pp. 363-370
-
-
Loftsson, T.1
-
15
-
-
80051674971
-
Pharmaceutical applications of cyclodextrins: Effects on drug permeation through biological membranes
-
Loftsson, T., and Brewster, M.E. Pharmaceutical applications of cyclodextrins: Effects on drug permeation through biological membranes. J. Pharm. Pharmacol. 63:1119-1135, 2011
-
(2011)
J. Pharm. Pharmacol
, vol.63
, pp. 1119-1135
-
-
Loftsson, T.1
Brewster, M.E.2
-
16
-
-
0004911318
-
Carbonic anhydrase inhibitors
-
Ritch, R., Shields, M.B., Krupin, T., eds Mosby
-
Lippa EA. Carbonic anhydrase inhibitors. In: Ritch, R., Shields, M.B., Krupin, T., eds. The Glaucomas. St Louis: Mosby; 1996; p. 1463-1481
-
(1996)
The Glaucomas. St Louis
, pp. 1463-1481
-
-
Lippa, E.A.1
-
17
-
-
0026517344
-
Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor
-
Lippa, E.A., Carlson L-E, Ehinger, B., et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch. Ophthalmol. 110:495-499, 1992
-
(1992)
Arch. Ophthalmol
, vol.110
, pp. 495-499
-
-
Lippa, E.A.1
Carlson, L.-E.2
Ehinger, B.3
-
18
-
-
0026032045
-
MK-507 versus sezolamide Comparative efficacy of two topically active carbonic anhydrase inhibitors
-
Lippa EA Schuman, J.S., Higginbotham, E.J., et al. MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophtalmology. 98:308-312, 1991
-
(1991)
Ophtalmology
, vol.98
, pp. 308-312
-
-
Lippa, E.A.1
Schuman, J.S.2
Higginbotham, E.J.3
-
19
-
-
0027515720
-
Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor
-
Wilkerson, M., Cyrlin, M., Lippa, E.A., et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch. Ophthalmol. 111:1343-1350, 1993
-
(1993)
Arch. Ophthalmol
, vol.111
, pp. 1343-1350
-
-
Wilkerson, M.1
Cyrlin, M.2
Lippa, E.A.3
-
20
-
-
9444268112
-
The Dorzolamide Dose-Response Study Group: A six-week dose response study of the ocular hypotensive effect of dorzolamide with a one-year extension
-
Strahlman, E., Tipping, R., and Vogel, R. The Dorzolamide Dose-Response Study Group: A six-week dose response study of the ocular hypotensive effect of dorzolamide with a one-year extension. AM. J. Opththalmol. 122:183-194, 1996
-
(1996)
AM. J. Opththalmol
, vol.122
, pp. 183-194
-
-
Strahlman, E.1
Tipping, R.2
Vogel, R.3
-
21
-
-
0033775214
-
Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension
-
Guomundsdó ttir, E., Stefánsson, E., Bjarnadó ttir, G., et al. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension. Invest. Ophthalmol. Vis. Sci. 41:3552-3554, 2000
-
(2000)
Invest. Ophthalmol. Vis. Sci
, vol.41
, pp. 3552-3554
-
-
Guomundsdóttir, E.1
Stefánsson, E.2
Bjarnadóttir, G.3
-
22
-
-
0029891955
-
A controlled clinical trial of dorzolamide: A single-centre subset of a multicentre study
-
Simpson, A.J., Gray, T.B., and Ballantyne, C. A controlled clinical trial of dorzolamide: A single-centre subset of a multicentre study. Aust. N. Z. J. Ophthalmol. 24:39-42, 1996
-
(1996)
Aust. N. Z. J. Ophthalmol
, vol.24
, pp. 39-42
-
-
Simpson, A.J.1
Gray, T.B.2
Ballantyne, C.3
-
23
-
-
77956937545
-
Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery
-
Ammar, H.O., Salama, H.A., Ghorab, M., and Mahmoud, A.A. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug. Dev. Ind. Pharm. 36:1330-1339, 2010
-
(2010)
Drug. Dev. Ind. Pharm
, vol.36
, pp. 1330-1339
-
-
Ammar, H.O.1
Salama, H.A.2
Ghorab, M.3
Mahmoud, A.A.4
-
24
-
-
0030318702
-
A new electromechanical method for measuring intraocular pressure
-
Kontiola, A. A new electromechanical method for measuring intraocular pressure. Doc. Ophthalmol. 93:265-276, 1997
-
(1997)
Doc. Ophthalmol
, vol.93
, pp. 265-276
-
-
Kontiola, A.1
-
25
-
-
51049110094
-
Pascal icare and goldmann applanation tonometry-A comparative study
-
Jóhannesson, G., Hallberg, P., Eklund, A., and Lindén, C. Pascal, ICare and Goldmann applanation tonometry-A comparative study. Acta. Ophthalmol. 86:614-621, 2008
-
(2008)
Acta. Ophthalmol
, vol.86
, pp. 614-621
-
-
Jóhannesson, G.1
Hallberg, P.2
Eklund, A.3
Lindén, C.4
-
26
-
-
0027291601
-
Sources of error with use of Goldmann-Type tonometers
-
Whitacre, M.M., and Stein, R. Sources of error with use of Goldmann-Type tonometers. Surv. Ophthalmol. 38:1-30, 1993
-
(1993)
Surv. Ophthalmol
, vol.38
, pp. 1-30
-
-
Whitacre, M.M.1
Stein, R.2
-
27
-
-
70549092884
-
Comparison of ICare, dynamic contour tonometer, and ocular response analyzer with Goldmann applanation tonometer in patients with glaucoma
-
Vandewalle, E., Vandenbroeck, S., Stalmans, I., and Zeyen, T. Comparison of ICare, dynamic contour tonometer, and ocular response analyzer with Goldmann applanation tonometer in patients with glaucoma. Eur. J. Ophthalmol. 19:783-789, 2009
-
(2009)
Eur. J. Ophthalmol
, vol.19
, pp. 783-789
-
-
Vandewalle, E.1
Vandenbroeck, S.2
Stalmans, I.3
Zeyen, T.4
-
28
-
-
56149126404
-
Tonometry through the Ages
-
Kniestedt, C., Punjabi, O., Lin, S., and Stamper, R.L. Tonometry through the Ages. Surv. Ophthalmol. 2008:53, 568-591
-
(2008)
Surv. Ophthalmol
, vol.53
, pp. 568-591
-
-
Kniestedt, C.1
Punjabi, O.2
Lin, S.3
Stamper, R.L.4
|